213 related articles for article (PubMed ID: 34103603)
1. Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy.
Yoon J; Yoon W; Na SK; Lee J; Kim CG; Kim JW; Cho HJ
Sci Rep; 2021 Jun; 11(1):12052. PubMed ID: 34103603
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Pachychoroid Neovasculopathy.
Cho HJ; Jung SH; Cho S; Han JO; Park S; Kim JW
J Ocul Pharmacol Ther; 2019 Apr; 35(3):174-181. PubMed ID: 30807236
[TBL] [Abstract][Full Text] [Related]
3. Intraocular Vascular Endothelial Growth Factor Levels in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.
Hata M; Yamashiro K; Ooto S; Oishi A; Tamura H; Miyata M; Ueda-Arakawa N; Takahashi A; Tsujikawa A; Yoshimura N
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):292-298. PubMed ID: 28114590
[TBL] [Abstract][Full Text] [Related]
4. Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.
Kato Y; Oguchi Y; Omori T; Shintake H; Tomita R; Kasai A; Ogasawara M; Sugano Y; Itagaki K; Ojima A; Machida T; Sekine H; Sekiryu T
Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):39. PubMed ID: 33252634
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration.
Matsumoto H; Hiroe T; Morimoto M; Mimura K; Ito A; Akiyama H
Jpn J Ophthalmol; 2018 Mar; 62(2):144-150. PubMed ID: 29411171
[TBL] [Abstract][Full Text] [Related]
6. One-year outcome of combination therapy with intravitreal anti-vascular endothelial growth factor and photodynamic therapy in patients with pachychoroid neovasculopathy.
Kitajima Y; Maruyama-Inoue M; Ito A; Sato S; Inoue T; Yamane S; Kadonosono K
Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1279-1285. PubMed ID: 32236705
[TBL] [Abstract][Full Text] [Related]
7. Vanishing pachy-choroid in pachychoroid neovasculopathy under long-term anti-vascular endothelial growth factor therapy.
Schworm B; Luft N; Keidel LF; Kreutzer TC; Herold TR; Priglinger SG; Siedlecki J
BMC Ophthalmol; 2021 Jun; 21(1):269. PubMed ID: 34193089
[TBL] [Abstract][Full Text] [Related]
8. Changes in Choroidal Thickness After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor in Pachychoroid Neovasculopathy.
Padrón-Pérez N; Arias L; Rubio M; Lorenzo D; García-Bru P; Català-Mora J; Caminal JM
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1119-1124. PubMed ID: 29490349
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes in eyes with polypoidal choroidal vasculopathy with poor baseline visual acuity.
Kim JH; Kim JW; Lee TG; Lew YJ
J Ocul Pharmacol Ther; 2015 May; 31(4):241-7. PubMed ID: 25786032
[TBL] [Abstract][Full Text] [Related]
10. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
Lee H; Ji B; Chung H; Kim HC
Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal anti-vascular endothelial growth factor and combined photodynamic therapy for pachychoroid neovasculopathy: long-term treatment outcomes.
Tanaka N; Azuma K; Aoki S; Kitamoto K; Ueda K; Fujino R; Inoue T; Obata R
Graefes Arch Clin Exp Ophthalmol; 2024 Jun; 262(6):1811-1818. PubMed ID: 38294513
[TBL] [Abstract][Full Text] [Related]
12. Anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy with polyps resembling grape clusters.
Lee JH; Lee WK
Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):645-51. PubMed ID: 26138657
[TBL] [Abstract][Full Text] [Related]
13. Progression of Pachychoroid Neovasculopathy into Aneurysmal Type 1 Choroidal Neovascularization or Polypoidal Choroidal Vasculopathy.
Siedlecki J; Klaas JE; Keidel LF; Asani B; Luft N; Priglinger SG; Schworm B
Ophthalmol Retina; 2022 Sep; 6(9):807-813. PubMed ID: 35398547
[TBL] [Abstract][Full Text] [Related]
14. The association of choroidal structure and its response to anti-VEGF treatment with the short-time outcome in pachychoroid neovasculopathy.
Azuma K; Tan X; Asano S; Shimizu K; Ogawa A; Inoue T; Murata H; Asaoka R; Obata R
PLoS One; 2019; 14(2):e0212055. PubMed ID: 30763369
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes of pachychoroid neovasculopathy with photodynamic therapy and anti-vascular endothelial growth factor.
Roy R; Saurabh K; Shah D; Goel S
Indian J Ophthalmol; 2019 Oct; 67(10):1678-1683. PubMed ID: 31546507
[TBL] [Abstract][Full Text] [Related]
16. One-year outcomes of half-fluence photodynamic therapy combined with intravitreal injection of aflibercept for pachychoroid neovasculopathy without polypoidal lesions.
Matsumoto H; Mukai R; Kikuchi Y; Morimoto M; Akiyama H
Jpn J Ophthalmol; 2020 Mar; 64(2):203-209. PubMed ID: 32016666
[TBL] [Abstract][Full Text] [Related]
17. Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX Study.
Spooner KL; Fraser-Bell S; Cozzi M; Staurenghi G; Invernizzi A; Monteduro D; Munk MR; Hong T; Chang AA
Ophthalmology; 2020 Dec; 127(12):1663-1673. PubMed ID: 32544561
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience of switching anti-VEGF therapy from ranibizumab to aflibercept in age-related choroidal neovascularization.
Van Lancker L; Petrarca R; Moutsouris K; Masaoutis P; Kampougeris G
Eur J Ophthalmol; 2017 May; 27(3):342-345. PubMed ID: 27739561
[TBL] [Abstract][Full Text] [Related]
19. Pachychoroid neovasculopathy has clinical properties that differ from conventional neovascular age-related macular degeneration.
Kuranami A; Maruko R; Maruko I; Hasegawa T; Iida T
Sci Rep; 2023 May; 13(1):7379. PubMed ID: 37149627
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy.
Miki A; Kusuhara S; Otsuji T; Kawashima Y; Miki K; Imai H; Nakamura M; Tsujikawa A
PLoS One; 2021; 16(3):e0248760. PubMed ID: 33755678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
